Загрузка...
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-induced Colon Cancer in F344 Rat Model
Recent observational studies suggest that bisphosphonates (BPs) and anti-diabetes drugs are associated with colorectal cancer (CRC) risk reduction. Hence, we evaluated the CRC preventive effects of BPs (Zometa; Zom; and Fosamax; Fos), individually and when combined with metformin (Met), in azoxymeth...
Сохранить в:
| Опубликовано в: : | Cancer Prev Res (Phila) |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7007371/ https://ncbi.nlm.nih.gov/pubmed/31699708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-19-0265 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|